Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
JDOC
66
HOLDINGS
8%
ALSO IN PSIL
PSIL
35
HOLDINGS
31%
ALSO IN JDOC
SECTOR DRIFT (JDOC minus PSIL)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in JDOC |
Weight in PSIL |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 7.9% | 4.7% | 4.7% |
|
ABBVIE INC | 8.2% | 4.5% | 4.5% |
|
JOHNSON & JOHNSON | 4.9% | 4.3% | 4.3% |
|
NEUROCRINE BIOSCIENCES INC | 0.8% | 4.5% | 0.8% |
JDOC Overweight Relative to PSIL
|
MERCK & CO. INC. | 5.1% |
|
THERMO FISHER SCIENTIFIC INC | 4.6% |
 |
NOVARTIS AG | 4.2% |
 |
ASTRAZENECA PLC | 4.1% |
|
ABBVIE INC | 3.7% |
|
UNITEDHEALTH GROUP INC | 3.6% |
|
ELI LILLY & CO | 3.3% |
|
ABBOTT LABORATORIES | 2.9% |
|
DANAHER CORP | 2.8% |
 |
ARGEN-X SE | 2.7% |
JDOC Underweight Relative to PSIL
|
DEFINIUM THERAPEUTICS INC | -11.6% |
|
RELMADA THERAPEUTICS INC | -4.7% |
|
NEURONETICS, INC. | -4.1% |
|
ALTO NEUROSCIENCE INC | -4.1% |
|
BRIGHT MINDS BIO | -3.7% |
|
NEUROCRINE BIOSCIENCES INC | -3.6% |
 |
ALKERMES PLC | -3.4% |
|
SUPERNUS PHARMACEUTICALS INC | -3.2% |
 |
NUMINUS WELLNESS INC | -0.7% |
|
INDIA GLOBALIZATION CAPITAL, INC. | -0.5% |